The QualityStocks Daily Monday, June 1st, 2020

Today's Top 3 Investment Newsletters

StockMarketWatch (CETXW) +510.67%

QualityStocks (AMAZ) +177.78%

SmallCapRelations (AESE) +61.63%

The QualityStocks Daily Stock List

Bragg Gaming Group, Inc. (BRGGF)

NetworkNewsWire, Global Banking and Finance, World Casino News, Simply Wall St, Dividend.com, Micro Small Cap, Nasdaq, TradingView, wallstreet-online, InvestorsHub, GlobeNewswire, Wall Street Analyzer, Small Cap Power, Investcom.com, Proactive Investors, TMXmoney, InvestorX, OTC Markets, Seeking Alpha, Stockwatch, Macroaxis, Wallmine, Dividend Investor, Barchart, Dividend Channel, Stockhouse, Morningstar, and Proactive Investors reported beforehand on Bragg Gaming Group, Inc. (BRGGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Bragg Gaming Group, Inc. is a next generation gaming group with pioneering technology, leading brands, and world-class management expertise. The Company’s portfolio includes ORYX Gaming, an innovative B2B (Business to Business) gaming technology platform and casino content aggregator, and GiveMeSport (GMS), a leading sports media outlet with greater than 26M fans, the number one Facebook Sport Publisher. OTCQX-listed, Bragg Gaming Group is headquartered in Toronto, Ontario.

In 2018, Bragg Gaming Group was created by way of two initial acquisitions. It specializes in identifying online gaming opportunities with an emphasis on B2B and B2C (Business to Consumer) gaming companies. Bragg Gaming has built business relationships throughout Asia, Europe, Central America, and North America.

The acquisition of Oryx is Bragg Gaming’s first step on the road to the creation of a new international gaming group. The Company plans to follow this with other acquisitions in the gaming sector. This is as it positions Bragg Gaming Group as a next generation gaming enterprise. On May 1, 2020, Bragg Gaming Group announced it completed the strategic review of its online media division. The Company has entered into a definitive share purchase agreement with SN&CK Media Limited (SML) for the sale of its media division, including GiveMeSport (GMS).

With this Agreement, Bragg Gaming Group will receive a total consideration of up to £400,000 for the sale of its online media division. The consideration for the media division comprises an upfront cash payment of £50,000 upon completion, in addition to 10 percent of the gross revenues from the media division for a period of 21 months following the completion.

In August of 2019, Bragg Gaming Group previously announced a strategic review of its online media division, which extensive eight month review process was completed with the sale of its online media division to SML. Mr. Dominic Mansour, Chief Executive Officer of Bragg Gaming Group, said: “The completion of the strategic review process and the execution of the Agreement for the sale of Bragg's online media division to SML will allow us to focus our efforts and resources on Oryx, our B2B business, which is growing at an exponential rate.”

Bragg Gaming Group, Inc. (BRGGF), closed Monday's trading session at $0.293, up 9.7378%, on 200,726 volume with 53 trades. The average volume for the last 3 months is 22,050 and the stock's 52-week low/high is $0.104000002/$0.348100006.

GBT Technologies, Inc. (GTCH)

OTC Dynamics, Zacks, Real Investment Advice, Whale Wisdom, GuruFocus, Venture Line, Stock Day Media, Finbox, TipRanks, Wallet Investor, Corporate Information, Stockhouse, Nasdaq, Investing.com, Investors Hangout, Stockwatch, Financial Buzz, InvestorsHub, OTC.Watch, Street Insider, Market Screener, Investor Ideas, last10k, GlobeNewswire, Simply Wall St, Dividend.com, Super Stock Screener, and Dividend Investor reported previously on GBT Technologies, Inc. (GTCH), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GBT Technologies, Inc. specializes in the development of Internet of Things (IoT) and Artificial Intelligence (AI) enabled networking and tracking technologies. A development-stage enterprise, it has a portfolio of Intellectual Property (IP) that, upon commercialization, will include smart microchips, mobile and security applications and protocols, and supporting cloud software. The Company formerly went by the name Gopher Protocol, Inc. It changed its name to GBT Technologies, Inc. in August of 2019. Established in 2009, GBT Technologies lists on the OTC Markets.

GBT’s system foresees the creation of a global mesh network. The heart of this system will be its advanced microchip technology, which can be installed in any mobile or fixed device worldwide. The Company envisions the system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing, and enhanced mobile features as an alternative to traditional carrier services.

GBT Technologies has its GopherInsight™ wireless mesh network technology platform and its Avant! AI, for mobile and fixed solutions. GBT’s Core Technology is a unique new platform with products that will change the way people interact with technology and each other.

The Company’s Platform Technology is called the aforementioned GopherInsight™. It uses “public” RF spectrum to facilitate a private network between enabled devices. Products that use GopherInsight™ can have network access without using traditional Bluetooth, Cellular or Satellite connectivity.

GBT Technologies’ 3D microchip patent is protecting the Company’s futuristic integrated circuit technology that introduces new systems and methods for IC (Integrated Circuit) manufacturing. The invention presents new die structure and orientation, expressly designed for deep nanometer range.

The technology enables the manufacturing of more devices on silicon in order to attain more circuits/features on die. In addition, it enables new IC architecture for larger designs within smaller areas while lowering the overall IC's power consumption.

In May, GBT Technologies announced that it was granted a continuation patent, that it is filing an additional patent, and filed a response and request for continued examination with the US Patent and Trademark Office (USPTO). The Company was granted continuation patent for tracking devices, systems and method using patch packages with embedded electronic circuits (US patent number: US 10,616,715 B2) on April 7, 2020, from the USPTO. The patent term usually is 20 years from the filing date of the priority application. Thus, this patent will expire November 7, 2036.

GBT Technologies, Inc. (GTCH), closed Monday's trading session at $0.0375, up 22.9508%, on 1,870,427 volume with 95 trades. The average volume for the last 3 months is 2,542,860 and the stock's 52-week low/high is $0.0087/$22.50.

n

GoldMining, Inc. (GLDLF)

TipRanks, OTC Markets, The Stock Market Watch, Market Screener, Morningstar, Junior Mining Network, Barchart, Nasdaq, Stocktwits, Wallet Investor, TradingView, Simply Wall St, GuruFocus, YCharts, Stockwatch, Investing.com, InvestorsHub, PR Newswire, Seeking Alpha, Dividend.com, and Stockhouse reported earlier on GoldMining, Inc. (GLDLF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A mineral exploration company, GoldMining, Inc. concentrates on the acquisition and development of gold assets in the Americas. It now controls a varied portfolio of resource-stage gold and gold-copper projects in the United States, Canada, Brazil, Colombia, and Peru. The Company previously went by the name Brazil Resources, Inc. It changed its name to GoldMining, Inc. in December of 2016. Incorporated in 2009, GoldMining has its head office in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets Group’s OTCQX.

The Company also owns a 75 percent interest in the Rea Uranium Project, positioned in the Western Athabasca Basin of the Province of Alberta. GoldMining has a portfolio of large, highly prospective gold and copper projects situated in mining friendly jurisdictions in the Americas. Its growth strategy involves continuing to make accretive acquisitions.

In early May, GoldMining announced that it completed a maiden mineral resource estimate for its 100 percent owned Yarumalito Gold-Copper Project, Antioquia, Colombia. The mineral resource estimate was prepared by Global Mineral Resource Services of Vancouver, British Columbia. It includes a pit constrained inferred resource of 66,271,000 tonnes grading 0.58 g/t gold (1,236,000 ounces) and 0.09% copper (129,262,000 pounds) or 0.70 g/t gold equivalent (1,502,000 ounces) using a 0.5 g/t gold equivalent cut-off. The estimate furthers GoldMining's unique position of holding one of the largest worldwide resource-stage gold portfolios among mid- and junior-tier mining companies.

Yarumalito is situated roughly 75 km southwest of the city of Medellin in the Department of Antioquia in Central Colombia and about 40 km south of GoldMining's La Mina Project. The Project consists of one concession for a total area of roughly 1,453 Ha. Yarumalito is GoldMining's third acquisition in the Mid Cauca Belt of central Colombia , which also hosts a number of multi-million ounce gold deposits owned by Zijin Mining, B2Gold, and Anglogold Ashanti.

GoldMining, Inc. (GLDLF), closed Monday's trading session at $1.12, even for the day, on 331,375 volume with 340 trades. The average volume for the last 3 months is 373,515 and the stock's 52-week low/high is $0.608820021/$1.59500002.

GrowLife, Inc. (PHOT)

Zacks, Investing.com, CRWE World, Awesome Penny Stocks, Stocks News Wire, Great Portfolio, Best Medical Marijuana Stocks, Equities.com, Market Exclusive, Stockwatch, Investors Underground, Wall Street Alerts, Simply Wall St, Investor Ideas, CannabisMarketCap, Green Rush Review, Stockhouse, Stockopedia, GlobeNewswire, Accesswire, Energy and Capital, InvestorsHub, TradingView, Insider Financial, and TMXmoney reported previously on GrowLife, Inc. (PHOT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

GrowLife, Inc. is one of the nation’s most recognized indoor cultivation product and service providers. It provides farming soil, hydroponics equipment, organic plant nutrients, and other products to specialty grow operations in the United States. The Company’s goal is to become the nation’s largest cultivation service provider for cultivating organics, herbs and greens and plant-based medicines. Established in 2012 and OTCQB-listed, GrowLife is based in Kirkland, Washington.

GrowLife provides essential goods and services through a network of local representatives covering the United States and Canada, regional centers, and its e-Commerce team. The Company’s retail locations are in Encino, California; Portland, Maine; and Calgary, Alberta. GrowLife also has its GrowLife Commercial operations.

GrowLife has a complete selection of cultivation products combined with logistics and distribution services. Its emphasis is on helping responsible cultivation operations efficiently control supply costs, manage build-out investments, track supply usage, and streamline workflows.

The Company has launched a platform for its previously majority acquired EZ-CLONE Enterprises, Inc. (EZ-CLONE) cloning and propagation company to serve as the commercial hemp cloning industry’s resource for innovation. The platform, ezclonehemp.com, is a trusted resource for cultivators to look for products and education on plant cloning and propagation, specifically designed for hemp growers. GrowLife received the patent for the design of its EZ-CLONE Pro Commercial Cloning System, “Aeroponics System with Rack and Tray”.

GrowLife experienced Revenue growth of 12.8 percent quarter-over-quarter in Q1 of 2020 versus Q4 of 2019, from $1,473k to $1,661k. The Company increased its Blended Gross Margins to 39.3 percent for the period ending March 31, 2020, up from Q4 of 2019 and last year’s overall that were 24.2 percent and 31.0 percent, respectively.

GrowLife centered on the market opportunity of selling hemp clones via its newly established brand “EZ-CLONEZ”, which sells exclusive strains of CBD (cannabidiol)-rich hemp clones. The Company continued to operate and provide essential business services on a State-by-State basis throughout the COVID-19 pandemic.

GrowLife, Inc. (PHOT), closed Monday's trading session at $0.20, off by 0.497512%, on 222,378 volume with 129 trades. The average volume for the last 3 months is 169,390 and the stock's 52-week low/high is $0.14/$1.23000001.

Liberty Health Sciences, Inc. (LHSIF)

Midas Letter, Zacks, New Cannabis Ventures, Pot Stock News, Profit Confidential, GuruFocus, The Deep Dive, TradingView, Nasdaq, Stockwatch, Cannabis Daily, Wallet Investor, Insider Financial, Alpha Query, Market Screener, Morningstar, Ceo.ca, Simply Wall St, Seeking Alpha, Macrotrends, Wallmine, PR Newswire, InvestorsHub, Barchart, Business Wire, Proactive Investors, OTC Markets, The Cannabis Investor, Stockhouse, Canadian Insider, GlobeNewswire, TMXmoney, Pot Network, and Technical420.com reported earlier on Liberty Health Sciences, Inc. (LHSIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Liberty Health Sciences, Inc. is a provider of high quality cannabis. Via its wholly-owned subsidiary, DFMMJ Investments, LLC (d/b/a Liberty Health Sciences Florida Ltd.), Liberty is licensed to produce and sell medical cannabis products in the State of Florida. It is also focused on acquiring other cannabis businesses and expanding its operations throughout the U.S. Liberty Health Sciences’ shares trade on the NasdaqCM.

The Company’s medical cannabis products include capsules, concentrates and distillates, flower, oral solutions, topicals and transdermals, and vaporizers. Liberty’s LHS360 Innovation Campus consists of 250,000 square feet of growing and production capacity. Moreover, the Company’s dispensaries feature private consultation rooms for one-on-one, individualized patient support that is uniquely targeted to their needs.

Recently, Liberty Health Sciences announced the expansion to its award-winning brand portfolio of premium products, which are available at all of its locations in Florida. On April 24, 2020, the Company launched its Liberty Health Sciences Shake brand to join its expanded and present portfolio that includes unique cannabis products and formats.

Liberty recently introduced Clarity Brands. This includes oil derived products on cartridges and G Pen pods and is available in all of the Company’s stores. In addition, Liberty recently introduced the all-new Papa's Herb classic 510 Cartridge pen to its Papa's Herb line up. Additionally, Liberty extended its popular offering of G Pen devices to include Roam, Elite, Connect, Gio, Pro, as well as Nova. Products under the Liberty Health Sciences umbrella include Clarity Brands, Zentient, Pretty Pistil, Papa's Herb, Mary's Medicinal, G Pen, PAX, and Lemon and Grass.

Mr. Victor Mancebo, Chief Executive Officer of Liberty Health Sciences, said, "Our passion and determination is to provide accessibility of best in class products at valued prices, especially during these challenging times. We are excited to grow our offering and provide the right cannabis derived medical options at a time when people need affordable ways to maintain their wellness and continue to practice social distancing."

Liberty Health Sciences, Inc. (LHSIF), closed Monday's trading session at $0.37, even for the day, on 385,605 volume with 223 trades. The average volume for the last 3 months is 1,011,931 and the stock's 52-week low/high is $0.225999996/$0.580150008.

New Pacific Metals Corp. (NUPMF)

Mines and Money, Gold Chartered, Mining-Journal, Rocket Reach, True Width, MarketWatch, Seeking Alpha, GlobeNewswire, Northern Miner, Streetwise Reports, Ceo.ca, Junior Mining Network, Barchart, Stockhouse, Morningstar, Mining.com, Stock Gumshoe, ValueWalk, Wallmine, Market Wire News, YCharts, OTC Markets, Street Insider, TradingView, MarketBeat, Resource World, Gold Stock Data, Simply Wall St, Wallet Investor, GuruFocus, Proactive Investors, and Insider Monkey reported earlier on New Pacific Metals Corp. (NUPMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

New Pacific Metals Corp. is an exploration and development company listed on the OTC Markets Group’s OTCQX. It owns the Silver Sand Project, in the Potosí Department of Bolivia, and the Tagish Lake Gold Project in Yukon, Canada. The Company previously went by the name New Pacific Holdings Corp. It changed its name to New Pacific Metals Corp. in July of 2017. New Pacific Metals has its corporate headquarters in Vancouver, British Columbia.

The Company, together with its subsidiaries, explores for silver, gold, lead, and zinc deposits. Its largest shareholders are Silvercorp Metals, Inc., the largest primary silver producer in China, and Pan American Silver Corp., one of the globe’s largest primary silver producers, which operates six mines, including the San Vicente mine in the Potosí Department of Bolivia.

New Pacific Metals acquired 100 percent interests of Minera Alcira S. A., the owner of the Silver Sand project in July of 2017. New Pacific, via its wholly-owned subsidiary Minera Alcira S.A., entered a Mining Production Contract (MPC) with the Bolivian Mining Corporation (COMIBOL) in Potosi, Bolivia on January 11, 2019.

The MPC covers 29 Temporary Special Authorizations (ATE’s) and 201 Cuadriculas are owned by COMIBOL, for a total area of approximately 57 square kilometers surrounding the Silver Sand core area. Therefore, New Pacific Metals has full exposure to the district potential of silver mineralization in a wide area of greater than 60 square kilometers.

New Pacific’s projects also include the Silverstrike Project. Silverstrike is situated roughly 140 kilometers (km) southwest of La Paz, Bolivia or about 450 km northwest of the Company’s Silver Sand Project. The Silverstrike Project comprises nine ATEs with an area of roughly 13km² presently in the process of conversion to ‘Mining Administrative Contracts’ before AJAM.

New Pacific Metals acquired the Tagish Lake Gold Project in 2010 via the 100 percent acquisition of Tagish Lake Gold Corp., which is continuing as a wholly-owned subsidiary of New Pacific Metals. By road, the Tagish Lake Gold Project is 80 kilometers south of Whitehorse, Yukon. It comprises 1,512 mineral claims encompassing approximately 254 square kilometers.

Last week, New Pacific Metals announced the filing of an independent Technical Report in accordance with National Instrument 43-101 Standards of Disclosure for Mineral Projects (NI 43-101) on its Silver Sand Deposit. The Technical Report, titled “Silver Sand Deposit Mineral Resource Report” dated May 25, 2020 (effective date of January 16, 2020) was prepared by AMC Mining Consultants (Canada) Ltd. (AMC), and is available under New Pacific’s profile on SEDAR at www.sedar.com.

New Pacific Metals Corp. (NUPMF), closed Monday's trading session at $4.29, up 1.9002%, on 223,568 volume with 526 trades. The average volume for the last 3 months is 277,777 and the stock's 52-week low/high is $1.45000004/$5.5999999.

Remark Holdings, Inc. (MARK)

Simply Wall St, Zacks, Stocktwits, Morningstar, The Deep Dive, Investors Observer, Barchart, YCharts, MacroTrends, Webull, Market Chameleon, Trade Ideas, Stockhouse, Investtech.com, InvestorsHub, Stockwatch, Barron’s, Newsheater, Ready Ratios, CSI Market, TradingView, and Seeking Alpha reported beforehand on Remark Holdings, Inc. (MARK), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Remark Holdings, Inc. is a diversified international technology company with leading artificial intelligence (AI) solutions and digital media properties. It primarily focuses on the development and deployment of AI-based solutions for businesses and software developers in manifold industries. Furthermore, the Company owns and operates digital media properties that deliver relevant, dynamic content. The Company formerly went by the name Remark Media, Inc. It changed its name to Remark Holdings, Inc. in April of 2017. Established in 2006, Remark Holdings is headquartered in Las Vegas, Nevada. It has additional operations in Los Angeles, California, and in Beijing, Shanghai, Chengdu and Hangzhou, China.

Remark delivers an integrated suite of AI solutions. These solutions enable businesses and organizations to solve problems, reduce risk and deliver positive outcomes. Its easy-to-install AI products are being rolled out in a wide array of applications within the retail, financial, public safety, and workplace arenas.

Remark’s portfolio companies include Sharecare, Bikini.com, Banks.com, and Remark Entertainment. Sharecare’s mission is to help each person build a longer, better life through enabling health transformation at the individual, organizational and community level. Sharecare has a wide-ranging platform. It enables people to go from assessment to action, and connect to the personalized information, evidence-based programs, benefits, community resources, and health services they need.

Bikini.com is a lifestyle destination and curated collection. Banks.com answers questions that people have concerning money. Remark Entertainment delivers entertainment to China via six key pillars that cover Licensing, Talent, Social, Content Creation, Movie Copromotion, and Content Production.

Last week, Remark Holdings announced the launch of a new website, RemarkThermal.com.

Kai-Shing Tao, Chairman and Chief Executive Officer of Remark Holdings, said, "Interest in our thermal imaging and scanning solutions is robust across many industries and we believe that enthusiasm warrants a dedicated site for information about our novel solutions. What differentiates Remark's thermal cameras are its capabilities beyond thermal temperature scanning. Our proprietary AI software enables monitoring various tasks including people counting, PPE enforcement such as mask wearing, social distancing compliance, contactless access to doors and gates, attendance management, touchless employee check in, object counts, behavior detection, intelligent surveillance and theft control."

Today, Remark Holdings announced its partnership with Hanvon Technology, a publicly listed Chinese systems integrator, won the Phase 2 implementation of China Mobile's contract for the transformation of its 17,800 corporate stores into smart retail stores. Remark's China-based subsidiary, KanKan AI, partnered with Hanvon Technology to successfully win the second phase of China Mobile's Smart Telecom Operator Store Project. The expectation is that the project will delivered over the next two years.

Remark Holdings, Inc. (MARK), closed Monday's trading session at $2.41, off by 8.7121%, on 21,276,134 volume with 59,540 trades. The average volume for the last 3 months is 30,918,090 and the stock's 52-week low/high is $0.25/$3.55999994.

Allied Esports Entertainment, Inc. (AESE)

Market Chameleon, Venture Beat, TipRanks, Investors Observer, last10k, Street Insider, Morningstar, Stockopedia, ShareInvestor.com, Nasdaq, ETF.com, Business Wire, GuruFocus, Simply Wall St, Seeking Alpha, TradingView, InvestorsHub, ETF Channel, Barchart, and YCharts reported beforehand on Allied Esports Entertainment, Inc. (AESE), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Allied Esports Entertainment, Inc. is a worldwide esports entertainment company listed on the NasdaqGS. It provides unique infrastructure, transformative live experiences, multiplatform content and interactive services to audiences globally via its strategic fusion of two strong entertainment brands: Allied Esports International, Inc. (Allied Esports) and the World Poker Tour (WPT). Incorporated in 2017, Allied Esports Entertainment is based in Irvine, California.

Allied Esports is an award-winning esports enterprise consisting of an international network of dedicated esports properties and content production facilities. Its mission is to connect players, streamers and fans globally through integrated arenas, including its flagship venue, HyperX Esports Arena Las Vegas, its fleet of mobile esports trucks, the HyperX Esports Trucks, and affiliate members of the Allied Esports Property Network that serve as competition battlegrounds and everyday content generation hubs.

World Poker Tour is the premier name in globally televised gaming and entertainment. It has brand presence in land-based tournaments, television, online, as well as mobile. In 2002, WPT sparked the worldwide poker boom with the creation of its iconic television show, now in its 18th season, based on a series of high-stakes poker tournaments. ClubWPT.com is an innovative online membership platform that offers inside access to the WPT.

This month, the WPT® and its partner, partypoker, announced the first WPT Online Series that will take place exclusively on the partypoker platform. The series will take place from May 10-26, 2020. The $3,200 buy-in, $5 million guaranteed WPT Online Championship will highlight the schedule. The WPT Online Championship will occur over the course of the entire festival, with Day 1 flights available starting on May 10.

The entire partypoker series includes $30 million in guarantees and $7 million for the WPT events on the schedule. partypoker.com is one of the oldest, most recognized and trusted online poker brands. Launched in August 2001, partypoker.com is one of the pioneers of the online poker industry.

Recently, Allied Esports Entertainment announced its financial results for Q4 and full year ended December 31, 2019, and also an update on a number of important business initiatives. Chief Executive Officer, Mr. Frank Ng, said, "Allied Esports Entertainment wrapped-up a transformational year ending with a strong fourth quarter highlighted by robust topline growth and continued execution of our strategic initiatives. Fourth quarter total revenues of $6.5 million increased 19.5 percent compared to the fourth quarter last year, driven by growth in both our Esports and Poker businesses…we also made significant progress in the fourth quarter with our strategic partnerships announced earlier in the year with Simon Property Group (NYSE: SPG) and TV Azteca and with this momentum, we announced a new relationship with Brookfield Properties…”

Allied Esports Entertainment, Inc. (AESE), closed Monday's trading session at $3.96, up 61.6327%, on 74,229,628 volume with 311,730 trades. The average volume for the last 3 months is 95,055 and the stock's 52-week low/high is $0.400000005/$10.8100004.

Amazing Energy Oil and Gas, Co. (AMAZ)

Proactive Investors, Investor Place, PR Newswire, Digital Journal, Energy Voice, Oil and Gas Investments Bulletin, Money Morning, Nasdaq, wallstreet-online, Tech Know Bits, and OilandGas360 reported beforehand on Amazing Energy Oil and Gas, Co. (AMAZ), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Amazing Energy Oil and Gas, Co. engages in the exploration, development, and production of oil and gas in Texas and East New Mexico. The Company operates leaseholds in the Permian Basin where it holds the rights within a 70,000-acre leasehold in Pecos County, Texas and is surrounded by large independent oil and gas companies. Overall, Amazing controls greater than 75,000 acres between their rights in Pecos County, Texas and assets in Lea County, New Mexico, and Walthall County, Mississippi. The Company also provides oilfield services to oil and gas well owners. The independent oil and gas exploration and production Company is based in Plano, Texas. Amazing Energy Oil and Gas lists on the OTC Markets Group’s OTCQB.

Jilpetco is a wholly-owned subsidiary of Amazing Energy Oil and Gas. Jilpetco is an oilfield services company. It owns and operates drilling, completion, and workers rigs. Jilpetco also leases operational services equipment.

Additionally, Amazing Energy Oil and Gas holds 16,904 gross acres in Lea County, New Mexico that is held by production. The Company primarily engages in the acquisition and exploitation of oil and natural gas properties with an emphasis on well-defined plays containing stacked pay zones such as the San Andres, Devonian, Pennsylvanian and Wolfcamp.

In West Sawyer, Lea County, New Mexico, Company development highlights include 16,904 gross acres; 10,051 net acres; 56 percent average Working Interest (WI) and operatorship. Four horizontal wells have been drilled. Net Production = 32.4 BOPD.

Pertaining to Pecos County, Amazing’s position accounts for rights within 70,000 acres leasehold (about 100 sq. miles); 100 percent WI; 75 percent Net Revenue Interest (NRI). A total of 26 wells have been drilled on the property. These are either producing or in the process of being completed.

Amazing Energy Oil and Gas has acquired assets located in Walthall County, Mississippi known as the Denver Mint Project. The new assets consist of 900 acres of leasehold, 9 oil wells and a saltwater disposal well. These assets include associated production facilities and infrastructure vital to substantially increase the asset's current production profile.

Recently, Amazing Energy Oil and Gas announced that it launched a new subsidiary called Amazing Energy Technologies, LLC (AET). It has brought on experienced professional, Mr. Mark Moss to run the new subsidiary as its Chief Executive Officer. The newly created entity will concentrate on the recovery and monetization of stranded natural gas from Amazing's existing assets and neighboring peers who presently either sell at a loss or flare associated gas production in the process of oil recovery.

Amazing Energy Technologies (AET) will address the stranded gas puzzle through delivering associated production and stranded gas to onsite portable units developed to convert gas to electricity and power onboard mining facilities for Bitcoin. It plans to deploy the first units in its Permian Basin acreage in the Summer of 2020.

Amazing Energy Oil and Gas, Co. (AMAZ), closed Monday's trading session at $0.015, up 177.7778%, on 126,119,751 volume with 1,934 trades. The average volume for the last 3 months is 5,887,528 and the stock's 52-week low/high is $0.001399999/$0.200000002.

Kalytera Therapeutics, Inc. (KALTF)

Penny Stock Hub, Dividend Investor, Proactive Investors, YCharts, Capital Network, OTC.Watch, Investing, The Street, OTC Markets, InvestorsHub, 4-Traders, Stockhouse, Stockwatch, Marketbeat, Investors Hangout, and Barchart reported earlier on Kalytera Therapeutics, Inc. (KALTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kalytera Therapeutics, Inc. is pioneering the development of a next generation of cannabinoid therapeutics. The Company is working to establish a leading position in the development of novel cannabinoid medicines for an array of important unmet medical needs, with an initial focus on Graft versus Host Disease (GvHD). Kalytera Therapeutics has its U.S. headquarters in Novato, California. A clinical-stage pharmaceutical company, its research facility is in Israel.

Kalytera Therapeutics is also developing a new class of proprietary cannabidiol (CBD) therapeutics. Its intention is to explore the use of CBD, a non-psychoactive cannabis constituent. The Company is working to advance a portfolio of synthetic, non-psychoactive cannabis-like molecules. Additionally, Kalytera will center on orphan conditions, with the aim of generating data in humans that may support follow-on studies in major conditions.

Kalytera received approval from the Institutional Review Board (IRB) at one of two clinical sites in Israel. This is to begin a Phase 2 study to evaluate cannabidiol (CBD) for the prevention of GvHD. The proposed study is a Phase 2, open label, multicenter trial. The trial is to evaluate the pharmacokinetic profile, safety, and efficacy of numerous doses of CBD for the prevention of GvHD following allogeneic hematopoietic cell transplantation (HCT). The proposed study will take place at the Rabin Medical Center, Beilinson, and the Rambam Health Care Campus, Haifa, in Israel.

The expectation is that Kalytera’s continuing Phase 2b clinical study evaluating the use of CBD in the prevention of GVHD will be completed early this year. Upon completion of the Phase 2b clinical study, Kalytera will begin preparations for the pivotal Phase 3 clinical study that will be required for Food and Drug Administration (FDA) approval.

The work that Kalytera Therapeutics is doing in GVHD consists of two separate product development programs. One is a program evaluating CBD for the prevention of acute GVHD. A separate program is evaluating CBD for the treatment of acute GVHD. The Company’s program in prevention of acute GVHD is more advanced than is the program in treatment of acute GVHD.

Kalytera Therapeutics is the exclusive licensee of two issued U.S. patents covering the use of CBD in the prevention and treatment of GVHD. It is also the exclusive licensee of pending patent applications in other jurisdictions for the use of CBD in the prevention and treatment of GVHD.

Recently, Kalytera Therapeutics announced positive interim data from its continuing Phase 2 clinical study evaluating cannabidiol (CBD) for the prevention of acute graft versus host disease (GVHD) following bone marrow transplant. Interim data from the initial 12-patient cohort support the following key findings to date.

No patients receiving oral CBD at the lowest study dose of 75 mg twice daily (BID) have developed grades 3 or 4 acute GVHD. One patient developed grade 2 acute GVHD, the least serious form of the disease. CBD has demonstrated a good safety and tolerability profile, with no significant adverse events relating to its use.

Kalytera Therapeutics, Inc. (KALTF), closed Monday's trading session at $0.0271, up 94.964%, on 195,734 volume with 33 trades. The average volume for the last 3 months is 170,331 and the stock's 52-week low/high is $0.000099999/$0.254000008.

Natcore Technology, Inc. (NTCXF)

Stockhouse, InvestorsHub, MarketWatch, OTC Markets, Business Insider, and StreetInsider reported on Natcore Technology, Inc. (NTCXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Natcore Technology, Inc. concentrates on using its proprietary Foil Cell technology to considerably lower the costs and improve the power output of solar cells. The Company is creating the next generation of solar cells. Natcore is developing two main technologies. These are low-cost, all-back-contact solar cell structures, and Black Silicon cells.

A solar R&D company, Natcore Technology is headquartered in Rochester, New York. The Company’s shares trade on the OTC Markets Group’s OTCQB.

The Company’s Foil Cell (All Back Contact Solar Cell) uses a high-speed, low temperature laser process. Natcore’s Black Silicon technology streamlines the path to low solar cell reflectance.

Natcore Technology has its Natcore Laboratory in Rochester. This is a 19,000 sq. ft. facility. It has 8,000 sq. ft. of ‘class 10,000’ clean room. The Company engages in the full solar cell process at this laboratory - from bare silicon wafer to working cells.

Regarding the Company’s Foil Cell Structure, the process involves multilayer foil metallization. Key features/properties include low cost contact metals and simplified manufacture. This includes low capital equipment cost, small factory footprint, and low temperature processing.

Natcore Technology has established exclusive licenses and/or joint research agreements with Rice University, the National Renewable Energy Laboratory (NREL), Fraunhofer ISE and the University of Virginia. The Company has received 33 patents; 32 patents are pending.

Recently, Natcore Technology announced it significantly streamlined the fabrication method for its pioneering Natcore Foil Cell™. This allows for even lower-cost production methods.

The Company is targeting greater than 25 percent real-world efficiency for its eventual production solar cells. This is approximately a 25 percent performance improvement over numerous high-end commercial cells being installed today.

The use of laser processing to create the Company’s unique, all-back-contact cell structure has been eliminated and replaced by a carrier selective contact process. This is combined with a foil metallization, which can be inexpensively made with high-speed roll-processing methods. Natcore has started an accelerated development program to produce a prototype with the new process, and also include production cost and efficiency modeling by independent authorities.

Natcore Technology, Inc. (NTCXF), closed Monday's trading session at $0.009, up 63.6364%, on 47,500 volume with 3 trades. The average volume for the last 3 months is 24,603 and the stock's 52-week low/high is $0.002099999/$0.037500001.

MetaStat, Inc. (MTST)

Goldman Small Cap Research, Innovative Marketing, Club Penny Stocks Network, OTCBB Journal, First Penny Picks, StocksImpossible, Pumps and Dumps, and The MicrocapNews reported previously on MetaStat, Inc. (MTST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

OTCQB-listed, MetaStat, Inc. is a personalized medicine company developing therapeutic and diagnostic treatment solutions for cancer patients. The Company develops and commercializes diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis - the process by which cancer spreads from a primary tumor through the bloodstream to other areas of the body.  MetaStat’s focus is on breast, prostate, lung, and colorectal cancers, where systemic metastasis is responsible for approximately 90 percent of all deaths.

A life sciences company, MetaStat is headquartered in Boston, Massachusetts. In essence, MetaStat’s core expertise includes an understanding of the mechanisms and pathways that drive tumor cell invasion and metastasis, and also drug resistance to certain targeted therapies and cytotoxic chemotherapies.

The basis of MetaStat’s function-based diagnostic platform technology is on the identification and understanding of the vital role of the mena protein and its isoforms  (a common pathway for the development of systemic metastatic disease in all epithelial-based solid tumors).

The design of the MetaSite Breast™ and MenaCalc™ product lines are to accurately stratify patients based on their individual risk of metastasis and to enable clinicians to better customize cancer treatment decisions through positively identifying patients with a high-risk of metastasis who need aggressive therapy and by sparing patients with a low-risk of metastasis from the damaging side effects and cost of chemotherapy. 

The MetaSite Breast™ test measures the process of systemic metastasis. MenaCalc™, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is widely applicable in solid epithelial-based cancers.

The intention of the MetaSite Breast™ test is for use in patients with early stage (stage 1-3), invasive breast cancer who have node-negative or node positive (1-3), estrogen receptor-positive, HER2-negative disease.

In August of 2017, MetaStat announced that accomplished drug developer, Renato T. Skerlj, Ph.D., joined the Company as a member of its Scientific and Clinical Advisory Board. Dr. Skerlj has more than 25 years of pharmaceutical experience in drug development resulting in two marketed drugs: Invanz® and Mozobil® and numerous drugs in clinical development.

He serves as Vice President of Drug Discovery and Preclinical Development at Lysosomal Therapeutics Inc. Dr. Skerlj is a Co-Founder and a Member of the Scientific Advisory Board of X4 Pharmaceuticals, Inc. He is also Co-Founder of Noliva Therapeutics.

MetaStat, Inc. (MTST), closed Monday's trading session at $0.011, up 214.2857%, on 700 volume with 1 trade. The average volume for the last 3 months is 847 and the stock's 52-week low/high is $0.0023/$0.0625.

Sunset Island Group, Inc. (SIGO)

MicrocapVoice, PennyStockSpy,  OTCPicks,  and 007 Stock Chat reported earlier on Sunset Island Group, Inc. (SIGO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sunset Island Group, Inc. provides consulting and advisory services to clients operating in the medical marijuana business space.  The Company concentrates on providing a licensed manufacturing facility to clients for producing products, including oils and edibles. Sunset Island Group has its corporate office in San Clemente,  California.

The Company’s vision is to establish a fully integrated business, which provides turnkey solutions to the medical cannabis industry. Its primary emphasis is on providing a licensed facility where companies can manufacture and produce their products. In addition, Sunset Island will provide distribution for companies via an established network of dispensaries.

Sunset Island Group earlier secured a lease on a property approved for cannabis cultivation. The Company for permits for 22,000 square feet of green house space. The expectation is that the 22,000 square feet of green house space will be able to produce up to 4,000 pounds of medical cannabis each year. 

Sunset Island announced last year that it initiated development of a CBD dietary supplement product. The initial product will feature a 2-oz stress relief beverage made from highest quality legal Hemp/CBD oil and real fruit.

Sunset Island will continue to develop products that will address the demands in the worldwide dietary supplements market. This market is targeted to soon reach greater than $200 billion.  The product will undergo development by a trained French Chef with more than two decades of experience in Product Development and Food Production.

Sunset Island Group is performing a retrofit to its current grow space that will considerably increase the amount of cannabis product produced with each harvest. Furthermore, the Company announced in November 2017 that it commenced an aggressive expansion of its cannabis product line.

The Company’s retro fit is two phases. Phase 1 is the retro fit of the present greenhouse operations. Phase 2 is the constructing of a new greenhouse on its bare land or retrofitting another greenhouse on the property.

The aim of the retro fit for Phase 1 is to increase the growable space in the current greenhouse to about 22,000 (with a vertical grow) with roughly 85 percent being canopy space (or around 19,000 square feet). The Company's objective is to yield 0.08-0.10 pounds per growable space and to have five harvests.

Sunset Island Group has received its temporary licenses from the State of California for Distribution, Cultivation and Manufacturing. The licenses are for Adult Use (Recreational) and Medicinal. The licenses permit Sunset Island to sell and transport its own product to dispensaries across California.

The manufacturing license allows it to start manufacturing products such as vape cartridges, edibles, as well as extracts. At present, Sunset Island is in the process of converting one of its cold storage rooms into a clean room to commence manufacturing these products.

Sunset Island Group, Inc. (SIGO), closed Monday's trading session at $0.10, up 53.8462%, on 14,000 volume with 7 trades. The average volume for the last 3 months is 7,322 and the stock's 52-week low/high is $0.023/$0.300000011.

China ShouGuan Investment Holding Group Corporation (CHSO)

OTC Markets, MarketWatch, InvestorsHub, Morningstar, GuruFocus, and StreetInsider reported on China ShouGuan Investment Holding Group Corporation (CHSO), and today we report on the Company, here at the QualityStocks Daily Newsletter.

China ShouGuan Investment Holding Group Corporation, with equity investment as its core, and operational entities as its foundation, is a large-scale integrated Investment holding Group. The OTCQB-listed Company has expanded its business layout that covers its investment bank business, the new energy industry, the environmental protection and energy-saving industry, the mining industry, the health industry, and also the hi-tech industry and more.

Incorporated in 2010, China ShouGuan Investment Holding Group Corporation is based in Shenzhen, China.

Regarding mining, China ShouGuan is a gold mining exploration, development, and advisory Company in the gold rich zones of Shandong and HeiLongJiang Provinces in the People’s Republic of China (PRC). The Company’s emphasis is acquiring or leasing under-performing mines in major mineral zones. It then finances their expanded exploration and production utilizing industry leading technologies.

China ShouGuan’s projects include the Dayuan Gold Mine, which covers an area of 0.3475 square kilometers in Longkou city of Shandong; and the mine in the Daxinganling area in Heilongjiang Province in the northeastern part of China.

China ShouGuan also provides mining technical advisory services. Moreover, the Company provides consulting services in the areas of geological analysis and mine exploration. The range of its mining business encompasses exploration, mining, beneficiation and technical consultation. Its principal business is gold mining, with geological prospecting and technical consultation as supplementary services.

China ShouGuan Investment Holding Group is diversifying its business. The Company has its Pro-Environment; Eco-Agriculture; Health, and Investment initiatives. Pertaining to Pro-Environment, it entered into the environmental protection field through beginning with sewage sludge treatment and disposal. Relying on its ion fractionation sewage sludge treatment technology, the Company provides integral services for sewage sludge treatment projects.

Regarding Eco-Agriculture, the agricultural company affiliated to Shouguan Group is one of the first companies to introduce and plant, and also work on product research of the Melaleuca tree in China. Concerning Health, China Shouguan’s commitment is to the development of the health industry, along with setting up funding and concentrating on the development of life sciences, health products, and investing in the health industry. Additionally, the Investment business line of China Shouguan covers industrial investment, financial investment, private equity fund management, investment banking services, and more.

China ShouGuan Investment Holding Group Corporation (CHSO), closed Monday's trading session at $0.019, up 131.7073%, on 2,700 volume with 1 trade. The average volume for the last 3 months is 2,293 and the stock's 52-week low/high is $0.006/$0.090000003.

The QualityStocks Company Corner

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group (NASDAQ: MEDS), through its virtual healthcare subsidiary Bonum Health, provides telehealth services and prescription ordering via teleconferences that are conducted using smart devices. To view the full article, visit http://nnw.fm/81m7D

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Monday's trading session at $5.87, up 9.5149%, on 26,198 volume with 179 trades. The average volume for the last 3 months is 121,600 and the stock's 52-week low/high is $2.94000005/$11.6000003.

Recent News

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Among the many changes wrought by COVID-19, those within the manufacturing and supply chain sectors will likely be far reaching and long lasting. The epidemic has exposed fundamental weaknesses in the system, some of which may be solved through advanced software and technologies, including 3D metal printing. Sigma Labs Inc. (NASDAQ: SGLB), a leading developer of quality-assurance software in the commercial 3D-metal-printing space, may benefit from the trend.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Monday's trading session at $2.6934, up 3.9923%, on 1,191,125 volume with 4,158 trades. The average volume for the last 3 months is 480,193 and the stock's 52-week low/high is $1.97000002/$17.00.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI), through its Helomics subsidiary, is leveraging its proprietary database of more than 150,000 tumor genomic and drug response profiles to improve cancer outcomes. To view the full article, visit http://nnw.fm/4GVUg

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Monday's trading session at $1.60, up 3.8961%, on 664,328 volume with 1,374 trades. The average volume for the last 3 months is 1,032,768 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies Inc. (CSE:XRO)(OTCQB:EXROF) was pleased today to announce its first-quarter 2020 financial results for the three months ended March 31, 2020. "Exro is in full force at commercializing its patented Coil Switching Technology. We engaged multiple partnerships with manufacturers during the first quarter such as Finland's Aurora Powertrains Oy ("Aurora") and Clean Seed Capital Group Ltd. ("Clean Seed") along with the partnerships from 2019, Motorino Electric Bike, Potencia and Templar Marine. We are in talks with several potential partners to build prototypes that will be implanted into the field" said CEO Sue Ozdemir.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Monday's trading session at $0.425, up 13.062%, on 476,798 volume with 172 trades. The average volume for the last 3 months is 171,920 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

Through a recently announced partnership, PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) and Source Digital will join forces to promote PowerBand’s innovative auto trading platform that provides car buying and financing trucks with never-seen-before simplicity, speed, and cost-efficiency. The trading platform will be promoted via Source Digital’s unique in-video advertising platform, designed to provide an enhanced viewer experience, help customers improve their return on investment while offering an overall more engaging and enjoyable experience for customers and users.

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Monday's trading session at $0.13785, even for the day, on 64,610 volume. The average volume for the last 3 months is 38,518 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in California, today announced the re-launch of its best-selling* limited edition Rainbow Sherbet cannabis-infused gummies for Pride 2020. According to the update, the Company is collaborating with the SF Queer Nightlife Fund (the “SF QNF”) as part of its commitment to strengthening and supporting the communities in which it operates and sells products. To view the full press release, visit http://cnw.fm/L8dXj

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Monday's trading session at $0.62, off by 7.7848%, on 76,398 volume with 63 trades. The average volume for the last 3 months is 37,134 and the stock's 52-week low/high is $0.279000014/$4.03999996.

Recent News

The Movie Studio Inc. (OTC: MVES)

The QualityStocks Daily Newsletter would like to spotlight The Movie Studio Inc. (OTC: MVES).

Vertically integrated motion-picture production company The Movie Studio (OTC: MVES) announced in April that it signed a licensing and distribution agreement with FILMHUB, an online marketplace for film creators and streaming services (http://nnw.fm/gTU15). To view the full article, visit http://nnw.fm/w3PcV. Also today, NetworkNewsWire released a report on the company detailing how, in a recent survey of 2,600 people in the U.S., an astounding 64% of respondents said that they had either severed their ties with their television cable provider or were actively planning to – with the figure rising to 74% within the 18 to 34 age bracket (http://nnw.fm/pE1rH ). 

The Movie Studio Inc. (OTC: MVES) is a vertically integrated motion picture production company focused on acquiring, developing, producing and distributing independent motion picture content for worldwide consumption via subscription and advertiser video on demand (SVOD/AVOD), over the top (OTT) platforms, foreign sales and various media devices. The company is currently engaged in establishing its own OTT VOD platform to integrate both its own and aggregated feature film projects, television programming and other media intellectual properties. The Movie Studio is disrupting traditional media content delivery systems with its digital business model of motion picture distribution, and the company intends to create a direct server access platform of its content with geo-fractured territories for worldwide distribution.

The company has launched The Movie Studio App on Google Play and the App Store, enabling users to both view the company’s content and potentially become part of it. The app is in the completion stage, and The Movie Studio is conducting its final beta test of the app’s unique “audition submission” function, leveraging the company’s “Watch Our Movies, Be in Our Movies!” content platform and “Everyone’s a Star” campaign, which will be marketed via social media. Using the app, subscribers can upload a thumbnail photo of themselves along with a selfie video audition submission that showcases them reading character dialog. Audition submissions will then be reviewed by producers for possible participation of the auditionee in upcoming feature films.

The audition submission function provides the subscriber the ability to disrupt traditional motion picture casting and management, enabling access to participation in The Movie Studio’s independent motion picture and media content. At the same time, for the company this significantly reduces capital expenditures associated with those traditional media mechanisms. The Movie Studio’s unique business model capitalizes on the global demand for film content through the production and distribution of its own films while also providing opportunities for direct viewer involvement in its content.

The company operates using a growth-by-acquisition strategy that includes:

  • Purchasing legacy film libraries.
  • Upgrading acquired films to 4K resolution and remonetizing with “new” film content on popular VOD streaming platforms across the internet.
  • Strategic partnerships and media content alignment with other OTT platforms and cross-collateralization of leverageable media assets for worldwide distribution.
  • Producing micro-budget motion picture content with substantial production value utilizing new 4K technology and the company’s extensive legacy resources and unique production process, thereby significantly reducing capital expenditures while allowing for the potential of significant return on investment (ROI) with one successful production.
  • Controlling its revenue streams through server-driven geo-fracturing global territories and its own OTT platform.

Currently, The Movie Studio is producing three upcoming feature films: “Cause and Effect,” “The Last Warhead” and “PEGASUS” — all with completed electronic press kits and pitch decks and fully produced motion picture-quality trailers ready for talent, distribution and financial integration.

The company has been successful in producing, casting and distributing its films on major SVOD platforms without recognizable stars, which reduces capital expenditures. However, The Movie Studio intends to integrate recognizable stars into the productions at value propositions either pre- or post-completion of the intellectual property.

Through successful beta testing, The Movie Studio has monetized film assets on the Amazon, tubi tv, Comcast and Showtime platforms.

The company’s proposed server-based model will provide licensing payment from global territories without third-party distribution fees, which have traditionally been as high as 35%.

Founded in 1961 and formerly known as Destination Television, Inc., the company changed its name to The Movie Studio, Inc. in November 2012. The Movie Studio is headquartered in Fort Lauderdale, Florida.

Cord-Cutting Creates Opportunity for VOD Players

Consumers are no longer content waiting for their favorite programming to come on the air – they expect instant streaming access where and how they want it. This has led to increased “cord cutting,” with consumers severing ties with their traditional pay TV providers in favor of digital streaming services.

With the advent of smart TVs with app integration, consumers can now watch what they want to watch when they want to watch it, fracturing traditional cable bundling mechanisms.

With pay TV usage steadily declining – satellite and cable TV businesses in the United States lost approximately 6 million customers in 2019 alone – streaming platforms are poised to potentially replace traditional pay TV distribution models altogether. Approximately 12,000 U.S. consumers are cutting the cord every day.

As this shift in media delivery continues and as digital devices become more sophisticated and bandwidth increases, VOD platforms have the potential to scale significantly. The Hollywood “streaming wars” of recent years have created an environment in which smaller competitors, like The Movie Studio, are able to emerge as major brands.

The Movie Studio Inc. (OTC: MVES), closed Monday's trading session at $0.007, off by 6.6667%, on 93,769 volume with 19 trades. The average volume for the last 3 months is 103,995 and the stock's 52-week low/high is $0.0063/$0.07.

Recent News

Cannabis Global, Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight Cannabis Global, Inc. (MCTC).

Cannabis Global, Inc. (MCTC) was highlighted today in a publication from Wall Street PR. The 2016 general election November vote was one of the biggest catalysts for the cannabis space. 2020 is shaping as potentially another similar situation, with 4 states already on the ballot for legalization (2 for recreational) and another 6 states pushing to get on the ballot (5 for recreational), making it potentially even more explosive for the overall legalization movement than we saw in the historic 2016 process.

Cannabis Global, Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

Cannabis Global, Inc. (MCTC), closed Monday's trading session at $0.55, up 0.182149%, on 77,461 volume with 73 trades. The average volume for the last 3 months is 40,010 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTC:LXRP) (CSE:LXX) (CNSX:LXX.CN), a global innovator in drug delivery platforms, announces it has retained PCG Advisory, Inc. ("PCG") of New York, to provide investor relations and digital marketing services to the Company in compliance with regulatory guidelines.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.298, up 1.0169%, on 33,259 volume with 28 trades. The average volume for the last 3 months is 117,074 and the stock's 52-week low/high is $0.217899993/$1.00999999.

Recent News

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF).

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is pleased to announce the voting results from its annual general and special meeting of shareholders held on June 1, 2020. A total of 36,983,055 common shares, representing approximately 46.88% of Willow's issued and outstanding shares, were represented at the Meeting.

Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (OTCQB: CANSF), closed Monday's trading session at $0.305, even for the day, on 35 volume with 1 trade. The average volume for the last 3 months is 9,784 and the stock's 52-week low/high is $0.239999994/$0.934599995.

Recent News

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) today announced that it will be releasing its Q1 Financial Statements on June 11, 2020 and will be including its 2019 year end results on this day, instead of Wednesday, June 3, 2020, as previously announced. The combined release is intended to give a more representative disclosure of the Company's financials at once. In addition, the Company will be hosting an investor conference call to discuss the results followed by a Q&A for investors. Siyata Mobile CEO Marc Seelenfreund and VP Sales Glenn Kennedy will host the call, which is scheduled to take place at 9:00 a.m. Eastern (6:00 a.m. Pacific) on Friday, June 12, 2020. Interested parties may join the call by dialing (866) 521-4909 (North America toll free) or (647) 427-2311 (International). To view the full press release, visit http://nnw.fm/cEbP9

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Monday's trading session at $0.10, off by 1.5748%, on 102,600 volume with 13 trades. The average volume for the last 3 months is 166,082 and the stock's 52-week low/high is $0.0731/$0.392500013.

Recent News

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)

The QualityStocks Daily Newsletter would like to spotlight Green Growth Brands Inc. (OTCQB: GGBXF).

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) was featured today in the 420 with CNW by CannabisNewsWire. A campaign to decriminalize marijuana in Ohio has been dealt a major blow after the U.S. Supreme Court declined to hear a case challenging local Ohio officials’ refusal to place decriminalization initiatives on municipal ballots on Tuesday. Back in 2018, activists submitted ballot initiatives to legalize marijuana in Garrettsville and Windham, but the Portage County Board of Elections determined that the initiatives could not appear before the voters.

Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.

In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.

Products under the Green Growth Brand umbrella include:

  • CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
  • Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
  • Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
  • Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
  • The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
  • XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.

Business Strategy

Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.

Management

Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.

Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.

Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.

CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.

CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.

Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.

Green Growth Brands Inc. (OTCQB: GGBXF), closed Monday's trading session at $0.0139, off by 2.1127%, on 1,485,692 volume with 150 trades. The average volume for the last 3 months is 1,049,692 and the stock's 52-week low/high is $0.0092/$2.80999994.

Recent News

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Monday's trading session at $0.0021, up 16.6667%, on 16,054,589 volume with 213 trades. The average volume for the last 3 months is 25,258,503 and the stock's 52-week low/high is $0.0017/$0.050500001.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.08, up 12.6761%, on 20,000 volume with 3 trades. The average volume for the last 3 months is 400,442 and the stock's 52-week low/high is $0.0215/$0.249799996.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.